Volume 15 Issue 4
May  2025
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Analysis  > 2025  >  15(4): 101143
Yining Cheng, Wenfeng Zhang, Qi Sun, Xue Wang, Qihang Shang, Jingyang Liu, Yubao Zhang, Ruijuan Liu, Changgang Sun. Probing the biological efficacy and mechanistic pathways of natural compounds in breast cancer therapy via the Hedgehog signaling pathway[J]. Journal of Pharmaceutical Analysis, 2025, 15(4): 101143. doi: 10.1016/j.jpha.2024.101143
Citation: Yining Cheng, Wenfeng Zhang, Qi Sun, Xue Wang, Qihang Shang, Jingyang Liu, Yubao Zhang, Ruijuan Liu, Changgang Sun. Probing the biological efficacy and mechanistic pathways of natural compounds in breast cancer therapy via the Hedgehog signaling pathway[J]. Journal of Pharmaceutical Analysis, 2025, 15(4): 101143. doi: 10.1016/j.jpha.2024.101143
shu

Probing the biological efficacy and mechanistic pathways of natural compounds in breast cancer therapy via the Hedgehog signaling pathway

doi: 10.1016/j.jpha.2024.101143

  • a. College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, 250014, China;

  • b. College of Traditional Chinese Medicine, Shandong Second Medical University, Weifang, Shandong, 261053, China;

  • c. College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, 250014, China;

  • d. State Key Laboratory of Quality Research in Chinese Medicine, and Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macao SAR, 999078, China;

  • e. Department of Oncology, Weifang Traditional Chinese Hospital, Weifang, Shandong, 261000, China

Funds:

This work was supported by the National Natural Science Foundation of China (Grant No.: 82174222) and Shandong Province Natural Science Foundation, China (Grant No.: ZR2021LZY015).

  • Received Date: May 22, 2024
  • Accepted Date: Nov. 05, 2024
  • Rev Recd Date: Oct. 25, 2024
  • Publish Date: Nov. 13, 2024
    Abstract
  • Breast cancer (BC) is one of the most prevalent malignant tumors affecting women worldwide, with its incidence rate continuously increasing. As a result, treatment strategies for this disease have received considerable attention. Research has highlighted the crucial role of the Hedgehog (Hh) signaling pathway in the initiation and progression of BC, particularly in promoting tumor growth and metastasis. Therefore, molecular targets within this pathway represent promising opportunities for the development of novel BC therapies. This study aims to elucidate the therapeutic mechanisms by which natural compounds modulate the Hh signaling pathway in BC. By conducting a comprehensive review of various natural compounds, including polyphenols, terpenes, and alkaloids, we reveal both common and unique regulatory mechanisms that influence this pathway. This investigation represents the first comprehensive analysis of five distinct mechanisms through which natural compounds modulate key molecules within the Hh pathway and their impact on the aggressive behaviors of BC. Furthermore, by exploring the structure-activity relationships between these compounds and their molecular targets, we shed light on the specific structural features that enable natural compounds to interact with various components of the Hh pathway. These novel insights contribute to advancing the development and clinical application of natural compound-based therapeutics. Our thorough review not only lays the groundwork for exploring innovative BC treatments but also opens new avenues for leveraging natural compounds in cancer therapy.
    • FullText(HTML)
  • loading
    • References(150)
  • [1]
    X.R. Yang, M.E. Sherman, D.L. Rimm, et al., Differences in risk factors for breast cancer molecular subtypes in a population-based study, Cancer Epidemiol. Biomarkers Prev. 16 (2007) 439-443.
    [2]
    S.A. O’Toole, D.A. Machalek, R.F. Shearer, et al., Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer, Cancer Res. 71 (2011) 4002-4014.
    [3]
    P. Fan, S. Fan, H. Wang, et al., Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway, Stem Cell Res. Ther. 4 (2013), 146.
    [4]
    C. Bao, J. Chen, J.T. Kim, et al., Amentoflavone inhibits tumorsphere formation by regulating the Hedgehog/Gli1 signaling pathway in SUM159 breast cancer stem cells, J. Funct. Foods 61 (2019), 103501.
    [5]
    Y. Huang, J. Fang, W. Lu, et al., A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling, Cell Chem. Biol. 26 (2019) 1143-1158.e6.
    [6]
    C. Bao, H. Namgung, J. Lee, et al., Daidzein suppresses tumor necrosis factor-αinduced migration and invasion by inhibiting hedgehog/Gli1 signaling in human breast cancer cells, J. Agric. Food Chem. 62 (2014) 3759-3767.
    [7]
    Y. Wang, Y. Sui, Y. Tao, Gambogic acid increases the sensitivity to paclitaxel in drug-resistant triple-negative breast cancer via the SHH signaling pathway, Mol. Med. Rep. 20 (2019) 4515-4522.
    [8]
    [8] [8] H. Li, F. Ni, Y. Zhang, et al., Rosmarinic acid inhibits stem-like breast cancer through hedgehog and Bcl-2/Bax signaling pathways, Pharmacogn. Mag. 15 (2019), 600.
    [9]
    M. Li, T. Guo, J. Lin, et al., Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway, J. Ethnopharmacol. 283 (2022), 114689.
    [10]
    P. Mohapatra, S.R. Satapathy, S. Siddharth, et al., Resveratrol and curcumin synergistically induces apoptosis in cigarette smoke condensate transformed breast epithelial cells through a p21(Waf1/Cip1) mediated inhibition of Hh-Gli signaling, Int. J. Biochem. Cell Biol. 66 (2015) 75-84.
    [11]
    C. Wu, B. Hong, C.T. Ho, et al., Targeting cancer stem cells in breast cancer: Potential anticancer properties of 6-shogaol and pterostilbene, J. Agric. Food Chem. 63 (2015) 2432-2441.
    [12]
    J.Y. So, J.J. Lin, J. Wahler, et al., A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer, PLoS One 9 (2014), e107616.
    [13]
    Y.C. Ko, H.S. Choi, R. Liu, et al., Physalin A, 13, 14-seco-16, 24-cyclo-steroid, inhibits stemness of breast cancer cells by regulation of hedgehog signaling pathway and yes-associated protein 1 (YAP1), Int. J. Mol. Sci. 22 (2021), 8718.
    [14]
    J. Che, F. Zhang, C. Zhao, et al., Cyclopamine is a novel Hedgehog signaling inhibitor with significant anti-proliferative, anti-invasive and anti-estrogenic potency in human breast cancer cells, Oncol. Lett. 5 (2013) 1417-1421.
    [15]
    K. Michno, K. Boras-Granic, P. Mill, et al., Shh expression is required for embryonic hair follicle but not mammary gland development, Dev. Biol. 264 (2003) 153-165.
    [16]
    J. Kurebayashi, N. Kanomata, Y. Koike, et al., Comprehensive immunohistochemical analyses on expression levels of hedgehog signaling molecules in breast cancers, Breast Cancer 25 (2018) 759-767.
    [17]
    Y. Tao, J. Mao, Q. Zhang, et al., Overexpression of Hedgehog signaling molecules and its involvement in triple-negative breast cancer, Oncol. Lett. 2 (2011) 995-1001.
    [18]
    M. Kubo, M. Nakamura, A. Tasaki, et al., Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer, Cancer Res. 64 (2004) 6071-6074.
    [19]
    H. Tukachinsky, L.V. Lopez, A. Salic, A mechanism for vertebrate Hedgehog signaling: Recruitment to Cilia and dissociation of SuFu-Gli protein complexes, J. Cell Biol. 191 (2010) 415-428.
    [20]
    C.Y. Wang, Y.C. Chang, Y.L. Kuo, et al., Mutation of the PTCH1 gene predicts recurrence of breast cancer, Sci. Rep. 9 (2019), 16359.
    [21]
    T. Shen, B. Han, Y. Leng, et al., Sonic Hedgehog stimulates migration of MCF-7 breast cancer cells through Rac1, J. Biomed. Res. 33 (2019) 297-307.
    [22]
    R. Du, X. Wang, L. Ma, et al., Adverse reactions of targeted therapy in cancer patients: A retrospective study of hospital medical data in China, BMC Cancer 21 (2021), 206.
    [23]
    Y.J. Chen, C.D. Kuo, S.H. Chen, et al., Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells, PLoS One 7 (2012), e37006.
    [24]
    X. Wang, N. Zhang, Q. Huo, et al., Huaier aqueous extract inhibits stem-like characteristics of MCF7 breast cancer cells via inactivation of hedgehog pathway, Tumour Biol. 35 (2014) 10805-10813.
    [25]
    M. Sun, N. Zhang, X. Wang, et al., Hedgehog pathway is involved in nitidine chloride induced inhibition of epithelial-mesenchymal transition and cancer stem cells-like properties in breast cancer cells, Cell Biosci. 6 (2016), 44.
    [26]
    J. Chen, D. Ma, C. Zeng, et al., Solasodine suppress MCF7 breast cancer stem-like cells via targeting Hedgehog/Gli1, Phytomedicine 107 (2022), 154448.
    [27]
    M. He, Y. Fu, Y. Yan, et al., The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients, Clin. Sci. (Lond) 129 (2015) 809-822.
    [28]
    S.K. Riaz, J.S. Khan, S.T.A. Shah, et al., Involvement of hedgehog pathway in early onset, aggressive molecular subtypes and metastatic potential of breast cancer, Cell Commun. Signal. 16 (2018), 3.
    [29]
    O. Zhulyn, E. Nieuwenhuis, Y.C. Liu, et al., Ptch2 shares overlapping functions with Ptch1 in Smo regulation and limb development, Dev. Biol. 397 (2015) 191-202.
    [30]
    P. Aza-Blanc, H.Y. Lin, A.R. Altaba, et al., Expression of the vertebrate Gli proteins in Drosophila reveals a distribution of activator and repressor activities, Development 127 (2000) 4293-4301.
    [31]
    J. Briscoe, P.P. Therond, The mechanisms of Hedgehog signalling and its roles in development and disease, Nat. Rev. Mol. Cell Biol. 14 (2013) 416-429.
    [32]
    S.J. Hatsell, P. Cowin, Gli3-mediated repression of Hedgehog targets is required for normal mammary development, Development 133 (2006) 3661-3670.
    [33]
    K.M. McDermott, B.Y. Liu, T.D. Tlsty, et al., Primary Cilia regulate branching morphogenesis during mammary gland development, Curr. Biol. 20 (2010) 731-737.
    [34]
    J.T. Happ, C.D. Arveseth, J. Bruystens, et al., A PKA inhibitor motif within SMOOTHENED controls Hedgehog signal transduction, Nat. Struct. Mol. Biol. 29 (2022) 990-999.
    [35]
    P. Kogerman, T. Grimm, L. Kogerman, et al., Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1, Nat. Cell Biol. 1 (1999) 312-319.
    [36]
    M. Duman-Scheel, L. Weng, S. Xin, et al., Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E, Nature 417 (2002) 299-304.
    [37]
    L.V. Goodrich, R.L. Johnson, L. Milenkovic, et al., Conservation of the hedgehog/patched signaling pathway from flies to mice: Induction of a mouse patched gene by Hedgehog, Genes Dev. 10 (1996) 301-312.
    [38]
    J. Motoyama, T. Takabatake, K. Takeshima, et al., Ptch2, a second mouse Patched gene is co-expressed with Sonic hedgehog, Nat. Genet. 18 (1998) 104-106.
    [39]
    R. Rohatgi, L. Milenkovic, M.P. Scott, Patched1 regulates hedgehog signaling at the primary Cilium, Science 317 (2007) 372-376.
    [40]
    G. Ozcan, PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2- breast cancer, Front Oncol. 13 (2023),1216438.
    [41]
    F. Mille, C. Thibert, J. Fombonne, et al., The Patched dependence receptor triggers apoptosis through a DRAL-caspase-9 complex, Nat. Cell Biol. 11 (2009) 739-746.
    [42]
    N. Pathan, H. Marusawa, M. Krajewska, et al., TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer, J. Biol. Chem. 276 (2001) 32220-32229.
    [43]
    M.F. Bijlsma, H. Damhofer, H. Roelink, Hedgehog-stimulated chemotaxis is mediated by smoothened located outside the primary Cilium, Sci. Signal. 5 (2012), ra60.
    [44]
    M.F. Bijlsma, K.S. Borensztajn, H. Roelink, et al., Sonic hedgehog induces transcription-independent cytoskeletal rearrangement and migration regulated by arachidonate metabolites, Cell. Signal. 19 (2007) 2596-2604.
    [45]
    M.M. Rahman, A. Hazan, J.L. Selway, et al., A novel mechanism for activation of GLI1 by nuclear SMO that escapes anti-SMO inhibitors, Cancer Res. 78 (2018) 2577-2588.
    [46]
    J. Ding, Y. Yang, P. Li, et al., TGF-Î21/SMAD3-driven GLI2 isoform expression contributes to aggressive phenotypes of hepatocellular carcinoma, Cancer Lett. 588 (2024), 216768.
    [47]
    A. Huang, J. Cheng, Y. Zhan, et al., Hedgehog ligand and receptor cooperatively regulate EGFR stability and activity in non-small cell lung cancer, Cell. Oncol. 47 (2024) 1405-1423.
    [48]
    H. Nakashima, M. Nakamura, H. Yamaguchi, et al., Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer, Cancer Res. 66 (2006) 7041-7049.
    [49]
    L. Zeng, C. Tang, M. Yao, et al., Phosphorylation of human glioma-associated oncogene 1 on Ser937 regulates Sonic Hedgehog signaling in medulloblastoma, Nat. Commun. 15 (2024), 987.
    [50]
    L. Di Marcotullio, A. Greco, D. Mazza, et al., Numb activates the E3 ligase Itch to control Gli1 function through a novel degradation signal, Oncogene 30 (2011) 65-76.
    [51]
    S. Das, S.K. Bailey, B.J. Metge, et al., O-GlcNAcylation of GLI transcription factors in hyperglycemic conditions augments Hedgehog activity, Lab. Invest. 99 (2019) 260-270.
    [52]
    I. Vorechovsky, K.P. Benediktsson, R. Toftgard, The patched/hedgehog/smoothened signalling pathway in human breast cancer: No evidence for H133Y SHH, PTCH and SMO mutations, Eur. J. Cancer 35 (1999) 711-713.
    [53]
    L.G. Harris, L.K. Pannell, S. Singh, et al., Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61, Oncogene 31 (2012) 3370-3380.
    [54]
    M.S. Tsai, A.E. Hornby, J. Lakins, et al., Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies, Cancer Res. 60 (2000) 5603-5607.
    [55]
    A.H. Polizio, P. Chinchilla, X. Chen, et al., Heterotrimeric Gi proteins link Hedgehog signaling to activation of Rho small GTPases to promote fibroblast migration, J. Biol. Chem. 286 (2011) 19589-19596.
    [56]
    D. Tempe, M. Casas, S. Karaz, et al., Multisite protein kinase A and glycogen synthase kinase 3beta phosphorylation leads to Gli3 ubiquitination by SCFbetaTrCP, Mol. Cell. Biol. 26 (2006) 4316-4326.
    [57]
    D. Trnski, M. Sabol, A. Gojevic, et al., GSK3Î2 and Gli3 play a role in activation of Hedgehog-Gli pathway in human colon cancer-Targeting GSK3Î2 downregulates the signaling pathway and reduces cell proliferation, Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 1852 (2015) 2574-2584.
    [58]
    S. Endoh-Yamagami, M. Evangelista, D. Wilson, et al., The mammalian Cos2 homolog Kif7 plays an essential role in modulating Hh signal transduction during development, Curr. Biol. 19 (2009) 1320-1326.
    [59]
    J. Mao, P. Maye, P. Kogerman, et al., Regulation of Gli1 transcriptional activity in the nucleus by Dyrk1, J. Biol. Chem. 277 (2002) 35156-35161.
    [60]
    M.A. Price, D. Kalderon, Proteolysis of the Hedgehog signaling effector Cubitus interruptus requires phosphorylation by Glycogen Synthase Kinase 3 and Casein Kinase 1, Cell 108 (2002) 823-835.
    [61]
    E. Miele, A. Po, F. Begalli, et al., Î2-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells, BMC Cancer 17 (2017), 488.
    [62]
    N.A. Riobo, K. Lu, X. Ai, et al., Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling, Proc. Natl. Acad. Sci. USA 103 (2006) 4505-4510.
    [63]
    B. Stecca, C. Mas, V. Clement, et al., Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways, Proc. Natl. Acad. Sci. USA 104 (2007) 5895-5900.
    [64]
    L. Song, D. Liu, Y. Zhao, et al., Sinomenine reduces growth and metastasis of breast cancer cells and improves the survival of tumor-bearing mice through suppressing the SHh pathway, Biomed. Pharmacother. 98 (2018) 687-693.
    [65]
    Z. Duan, H. Wang, D. Zhao, et al., Cooperatively transcriptional and epigenetic regulation of sonic hedgehog overexpression drives malignant potential of breast cancer, Cancer Sci. 106 (2015) 1084-1091.
    [66]
    W. Cui, L. Wang, Y. Wen, et al., Expression and regulation mechanisms of Sonic Hedgehog in breast cancer, Cancer Sci. 101 (2010) 927-933.
    [67]
    L. Wang, Y.L. Choi, X. Hua, et al., Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions, Mod. Pathol. 19 (2006) 675-683.
    [68]
    L.J. Wils, M.F. Bijlsma, Epigenetic regulation of the Hedgehog and Wnt pathways in cancer, Crit. Rev. Oncol. Hematol. 121 (2018) 23-44.
    [69]
    C. Liu, M. Qi, L. Li, et al., Natural cordycepin induces apoptosis and suppresses metastasis in breast cancer cells by inhibiting the Hedgehog pathway, Food Funct. 11 (2020) 2107-2116.
    [70]
    I. Wolf, S. Bose, J.C. Desmond, et al., Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer, Breast Cancer Res. Treat. 105 (2007) 139-155.
    [71]
    J. Sims-Mourtada, D. Yang, I. Tworowska, et al., Detection of canonical hedgehog signaling in breast cancer by 131-iodine-labeled derivatives of the sonic hedgehog protein, J. Biomed. Biotechnol. 2012 (2012), 639562.
    [72]
    W. Wu, X. Li, M. Qi, et al., Cordycepin inhibits growth and metastasis formation of MDA-MB-231 xenografts in nude mice by modulating the hedgehog pathway, Int. J. Mol. Sci. 23 (2022), 10362.
    [73]
    S. Massah, J. Foo, N. Li, et al., Gli activation by the estrogen receptor in breast cancer cells: Regulation of cancer cell growth by Gli3, Mol. Cell. Endocrinol. 522 (2021), 111136.
    [74]
    S.R. Sirkisoon, R.L. Carpenter, T. Rimkus, et al., TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment, Oncogene 39 (2020) 64-78.
    [75]
    H. Sasaki, Y. Nishizaki, C. Hui, et al., Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: Implication of Gli2 and Gli3 as primary mediators of Shh signaling, Development 126 (1999) 3915-3924.
    [76]
    X. Zhang, N. Harrington, R.C. Moraes, et al., Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo), Breast Cancer Res. Treat. 115 (2009) 505-521.
    [77]
    M. Liu, W. Zhang, W. Tang, et al., Isocyclopamine, a novel synthetic derivative of cyclopamine, reverts doxorubicin resistance in MCF-7/ADR cells by increasing intracellular doxorubicin accumulation and downregulating breast cancer stem-like cells, Tumour Biol. 37 (2016) 1919-1931.
    [78]
    C. Bao, M.C. Kim, J. Chen, et al., Sulforaphene interferes with human breast cancer cell migration and invasion through inhibition of hedgehog signaling, J. Agric. Food Chem. 64 (2016) 5515-5524.
    [79]
    X. Lei, Z. Li, Y. Zhong, et al., Gli1 promotes epithelial-mesenchymal transition and metastasis of non-small cell lung carcinoma by regulating snail transcriptional activity and stability, Acta Pharm. Sin. B 12 (2022) 3877-3890.
    [80]
    C. Bose, U. Das, T.K. Kuilya, et al., Cananginone abrogates EMT in breast cancer cells through hedgehog signaling, Chem. Biodivers. 19 (2022), e202100823.
    [81]
    C. Di Mauro, R. Rosa, V. D’Amato, et al., Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers, Br. J. Cancer 116 (2017) 1425-1435.
    [82]
    K. Nakamura, J. Sasajima, Y. Mizukami, et al., Hedgehog promotes neovascularization in pancreatic cancers by regulating Ang-1 and IGF-1 expression in bone-marrow derived pro-angiogenic cells, PLoS One 5 (2010), e8824.
    [83]
    Y. Sun, Y. Zhao, J. Yao, et al., Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-ΰB and NLRP3 inflammasome activation, Biochem. Pharmacol. 94 (2015) 142-154.
    [84]
    H. Li, J. Hu, S. Zhao, et al., Comparative study of the effect of baicalin and its natural analogs on neurons with oxygen and glucose deprivation involving innate immune reaction of TLR2/TNFα, J. Biomed. Biotechnol. 2012 (2012), 267890.
    [85]
    E. Meng, A. Hanna, R.S. Samant, et al., The impact of hedgehog signaling pathway on DNA repair mechanisms in human cancer, Cancers 7 (2015) 1333-1348.
    [86]
    H. Zhang, L. Hu, M. Cheng, et al., The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer, Oncol. Rep. 44 (2020) 2610-2620.
    [87]
    A.S. Cazet, M.N. Hui, B.L. Elsworth, et al., Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer, Nat. Commun. 9 (2018), 2897.
    [88]
    [88] X. Tang, L. Deng, Q. Chen, et al., Inhibition of Hedgehog signaling pathway impedes cancer cell proliferation by promotion of autophagy, Eur. J. Cell Biol. 94 (2015) 223-233.
    [89]
    M.N. Hui, A. Cazet, B. Elsworth, et al., Targeting the Hedgehog signalling pathway in triple negative breast cancer, J. Clin. Oncol. 36 (2018), e24216.
    [90]
    N. Yang, T. Zhou, X. Lei, et al., Inhibition of sonic hedgehog signaling pathway by thiazole antibiotic thiostrepton attenuates the CD44+/CD24-stem-like population and sphere-forming capacity in triple-negative breast cancer, Cell. Physiol. Biochem. 38 (2016) 1157-1170.
    [91]
    S. Mahsa Torabi, M. Rahaie, A. Ebrahimi, The effect of ginger extract on expression of Gli1 and Patched-1 genes involved in breast cancer signaling pathway under in vitro condition, Biomedicine 44 (2024) 107-113.
    [92]
    S.H. Kim, B.B. Adhikari, S. Cruz, et al., Targeted intracellular delivery of resveratrol to glioblastoma cells using apolipoprotein E-containing reconstituted HDL as a nanovehicle, PLoS One 10 (2015), e0135130.
    [93]
    Q. Fei, D. Kent, W.M. Botello-Smith, et al., Molecular mechanism of resveratrol’s lipid membrane protection, Sci. Rep. 8 (2018), 1587.
    [94]
    M.A. Qureshi, S. Javed, Investigating binding dynamics of trans resveratrol to HSA for an efficient displacement of aflatoxin B1 using spectroscopy and molecular simulation, Sci. Rep. 12 (2022), 2400.
    [95]
    H. Liao, J. Huang, J. Liu, et al., Resveratrol inhibits activation of microglia after stroke through triggering translocation of smo to primary Cilia, J. Pers. Med. 13 (2023), 268.
    [96]
    U. Saqib, T.T. Kelley, S.K. Panguluri, et al., Polypharmacology or promiscuity? structural interactions of resveratrol with its bandwagon of targets, Front. Pharmacol. 9 (2018), 1201.
    [97]
    C. Papaemmanouil, M.V. Chatziathanasiadou, C. Chatzigiannis, et al., Unveiling the interaction profile of rosmarinic acid and its bioactive substructures with serum albumin, J. Enzyme Inhib. Med. Chem. 35 (2020) 786-804.
    [98]
    S. Noor, T. Mohammad, M.A. Rub, et al., Biomedical features and therapeutic potential of rosmarinic acid, Arch. Pharm. Res. 45 (2022) 205-228.
    [99]
    V. Vasireddy, V.R. Chavali, V.T. Joseph, et al., Rescue of photoreceptor degeneration by curcumin in transgenic rats with P23H rhodopsin mutation, PLoS One 6 (2011), e21193.
    [100]
    A.M. Alli-Oluwafuyi, P.B. Luis, F. Nakashima, et al., Curcumin induces secretion of glucagon-like peptide-1 through an oxidation-dependent mechanism, Biochimie 165 (2019) 250-257.
    [101]
    M.A. Subhan, M.M. Islam, M.R.U. Chowdhury, Binding studies and effect of light on the conductance of intercalated curcumin into DNA, J. Sci. Res. 4 (2012), 411.
    [102]
    S.C. Gupta, S. Prasad, J.H. Kim, et al., Multitargeting by curcumin as revealed by molecular interaction studies, Nat. Prod. Rep. 28 (2011) 1937-1955.
    [103]
    N.S. Al-Radadi, Artichoke (Cynara scolymus L.,) mediated rapid analysis of silver nanoparticles and their utilisation on the cancer cell treatments, J. Comput. Theor. Nanosci. 15 (2018) 1818-1829.
    [104]
    S. Kasiri, B. Chen, A.N. Wilson, et al., Stromal Hedgehog pathway activation by IHH suppresses lung adenocarcinoma growth and metastasis by limiting reactive oxygen species, Oncogene 39 (2020) 3258-3275.
    [105]
    G. Zhang, Y. Liu, A.E. Ruoho, et al., Structure of the adenylyl cyclase catalytic core, Nature 386 (1997) 247-253.
    [106]
    T. Sheng, S. Chi, X. Zhang, et al., Regulation of Gli1 localization by the cAMP/protein kinase A signaling axis through a site near the nuclear localization signal, J. Biol. Chem. 281 (2006) 9-12.
    [107]
    I. Pateraki, J. Andersen-Ranberg, N.B. Jensen, et al., Total biosynthesis of the cyclic AMP booster forskolin from Coleus forskohlii, Elife 6 (2017), e23001.
    [108]
    P.A. Insel, R.S. Ostrom, Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling, Cell. Mol. Neurobiol. 23 (2003) 305-314.
    [109]
    L. Sapio, M. Gallo, M. Illiano, et al., The natural cAMP elevating compound forskolin in cancer therapy: Is it time? J. Cell. Physiol. 232 (2017) 922-927.
    [110]
    S. Mukhopadhyay, X. Wen, N. Ratti, et al., The ciliary G-protein-coupled receptor Gpr161 negatively regulates the Sonic hedgehog pathway via cAMP signaling, Cell 152 (2013) 210-223.
    [111]
    S. Shin, J. Wakabayashi, M.S. Yates, et al., Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide, Eur. J. Pharmacol. 620 (2009) 138-144.
    [112]
    X. Meng, J.C. Waddington, A. Tailor, et al., CDDO-imidazolide targets multiple amino acid residues on the Nrf2 adaptor, Keap1, J. Med. Chem. 63 (2020) 9965-9976.
    [113]
    M. Aguedo, L. Beney, Y. Wache, et al., Mechanisms underlying the toxicity of lactone aroma compounds towards the producing yeast cells, J. Appl. Microbiol. 94 (2003) 258-265.
    [114]
    S. Kumar Katakam, V. Tria, W.C. Sim, et al., The heparan sulfate proteoglycan syndecan-1 regulates colon cancer stem cell function via a focal adhesion kinase-Wnt signaling axis, FEBS J. 288 (2021) 486-506.
    [115]
    S. Pietrobono, S. Gagliardi, B. Stecca, Non-canonical hedgehog signaling pathway in cancer: Activation of GLI transcription factors beyond smoothened, Front. Genet. 10 (2019), 556.
    [116]
    M. Xin, X. Ji, L.K. De La Cruz, et al., Strategies to target the Hedgehog signaling pathway for cancer therapy, Med. Res. Rev. 38 (2018) 870-913.
    [117]
    R.F. Keeler, W. Binns, Teratogenic compounds of Veratrum californicum (Durand). I. Preparation and characterization of fractions and alkaloids for biologic testing, Can. J. Biochem. 44 (1966) 819-828.
    [118]
    P. Huang, S. Zheng, B.M. Wierbowski, et al., Structural basis of smoothened activation in hedgehog signaling, Cell 174 (2018) 312-324.e16.
    [119]
    J.K. Chen, J. Taipale, M.K. Cooper, et al., Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened, Genes Dev. 16 (2002) 2743-2748.
    [120]
    T. Nakamura, C. Komori, Y. Lee, et al., Cytotoxic activities of Solanum steroidal glycosides, Biol. Pharm. Bull. 19 (1996) 564-566.
    [121]
    C. Guinez, A.M. Mir, V. Dehennaut, et al., Protein ubiquitination is modulated by O-GlcNAc glycosylation, FASEB J. 22 (2008) 2901-2911.
    [122]
    J. Yang, W. Huang, W. Tan, Solasonine, A natural glycoalkaloid compound, inhibits gli-mediated transcriptional activity, Molecules 21 (2016), 1364.
    [123]
    M. Weissenberg, Isolation of solasodine and other steroidal alkaloids and sapogenins by direct hydrolysis-extraction of Solanum plants or glycosides therefrom, Phytochemistry 58 (2001) 501-508.
    [124]
    I.K. McDonald, J.M. Thornton, Satisfying hydrogen bonding potential in proteins, J. Mol. Biol. 238 (1994) 777-793.
    [125]
    R. Palermo, F. Ghirga, M.G. Piccioni, et al., Natural products inspired modulators of cancer stem cells-specific signaling pathways Notch and hedgehog, Curr. Pharm. Des. 24 (2018) 4251-4269.
    [126]
    J.A. Delbrouck, M. Desgagne, C. Comeau, et al., The therapeutic value of Solanum steroidal (glyco) alkaloids: A 10-year comprehensive review, Molecules 28 (2023), 4957.
    [127]
    M.M. Augustin, Discovery and Metabolic Engineering of Steroid Alkaloid Biosynthetic Genes from (Veratrum californicum), [master’s thesis], St. Louis: University of Missouri, (2015).
    [128]
    C.E. Coupland, S.A. Andrei, T.B. Ansell, et al., Structure, mechanism, and inhibition of Hedgehog acyltransferase, Mol. Cell 81 (2021) 5025-5038.e10.
    [129]
    J. Abramyan, Hedgehog signaling and embryonic craniofacial disorders, J. Dev. Biol. 7 (2019), 9.
    [130]
    M. Wijgerde, M. Ooms, J.W. Hoogerbrugge, et al., Hedgehog signaling in mouse ovary: Indian hedgehog and desert hedgehog from granulosa cells induce target gene expression in developing theca cells, Endocrinology 146 (2005) 3558-3566.
    [131]
    J.H. Kong, C. Siebold, R. Rohatgi, Biochemical mechanisms of vertebrate hedgehog signaling, Development 146 (2019), dev166892.
    [132]
    J. Jing, Z. Wu, J. Wang, et al., Hedgehog signaling in tissue homeostasis, cancers, and targeted therapies, Signal Transduct. Target. Ther. 8 (2023), 315.
    [133]
    N.M. Nguyen, J. Cho, Hedgehog pathway inhibitors as targeted cancer therapy and strategies to overcome drug resistance, Int. J. Mol. Sci. 23 (2022), 1733.
    [134]
    X. Qi, X. Li, Mechanistic insights into the generation and transduction of hedgehog signaling, Trends Biochem. Sci. 45 (2020) 397-410.
    [135]
    I.P. W, Hedgehog signaling, Curr. Top. Dev. Biol. 149 (2022) 1-58.
    [136]
    E. Petrova, J. Rios-Esteves, O. Ouerfelli, et al., Inhibitors of Hedgehog acyltransferase block Sonic Hedgehog signaling, Nat. Chem. Biol. 9 (2013) 247-249.
    [137]
    A.E. Owens, I. de Paola, W.A. Hansen, et al., Design and evolution of a macrocyclic peptide inhibitor of the sonic hedgehog/patched interaction, J. Am. Chem. Soc. 139 (2017) 12559-12568.
    [138]
    S. Habashy, A. Jafri, H.O. Osman, et al., Hedgehog pathway inhibitors: Clinical implications and resistance in the treatment of basal cell carcinoma, Cureus 13 (2021), e13859.
    [139]
    C. Fang, Y. Wang, Y. Li, Research progress of histone deacetylase inhibitor combined with immune checkpoint inhibitor in the treatment of tumor, Zhongguo Fei Ai Za Zhi 24 (2021) 204-211.
    [140]
    H. Shao, W. Liu, M. Liu, et al., Asymmetric synthesis of cyclopamine, a hedgehog (hh) signaling pathway inhibitor, J. Am. Chem. Soc. 145 (2023) 25086-25092.
    [141]
    A. Agyeman, B.K. Jha, T. Mazumdar, et al., Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding, Oncotarget 5 (2014) 4492-4503.
    [142]
    E. Peer, S. Tesanovic, F. Aberger, Next-generation hedgehog/GLI pathway inhibitors for cancer therapy, Cancers 11 (2019), 538.
    [143]
    T.K. Rimkus, R.L. Carpenter, S. Qasem, et al., Targeting the sonic hedgehog signaling pathway: Review of smoothened and GLI inhibitors, Cancers 8 (2016), 22.
    [144]
    J.Y. Chai, V. Sugumar, M.A. Alshawsh, et al., The role of smoothened-dependent and-independent hedgehog signaling pathway in tumorigenesis, Biomedicines 9 (2021), 1188.
    [145]
    N. Mahindroo, C. Punchihewa, N. Fujii, Hedgehog-Gli signaling pathway inhibitors as anticancer agents, J. Med. Chem. 52 (2009) 3829-3845.
    [146]
    J. Sims-Mourtada, L.M. Opdenaker, J. Davis, et al., Taxane-induced hedgehog signaling is linked to expansion of breast cancer stem-like populations after chemotherapy, Mol. Carcinog. 54 (2015) 1480-1493.
    [147]
    M. Xin, L. Zhang, J. Wen, et al., Synthesis and pharmacological evaluation of trifluoromethyl containing 4-(2-pyrimidinylamino)benzamides as Hedgehog signaling pathway inhibitors, Bioorg. Med. Chem. 24 (2016) 1079-1088.
    [148]
    Z. Zhang, V. Baubet, C. Ventocilla, et al., Stereoselective synthesis of F-ring saturated estrone-derived inhibitors of Hedgehog signaling based on cyclopamine, Org. Lett. 13 (2011) 4786-4789.
    [149]
    S.K. Riaz, Y. Ke, F. Wang, et al., Influence of SHH/GLI1 axis on EMT mediated migration and invasion of breast cancer cells, Sci. Rep. 9 (2019), 6620.
    [150]
    A. Hanna, B.J. Metge, S.K. Bailey, et al., Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer, Oncoimmunology 8 (2018), 1548241.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (418) PDF downloads(13) Cited by()
    Proportional views
    Related

    Copyright © Journal of Pharmaceutical Analysis

    E-mail: jpasubmit@126.com;  jpaeditor@xjtu.edu.cn   Tel:+86-029-88960092

    Address: Western China Science and Technology Innovation Harbour, Xixian New Area, Xi’an, 712000, China

    Email alert RSS

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return